title: Dabigatran in catheter ablation of atrial fibrillation: a call for a randomized control trial.
authors.affiliation: Kansas City, Missouri.
authors.forename: Aref A
authors.initials: AA
authors.lastname: Bin Abdulhak
authors.affiliation: Toledo, Ohio.
authors.forename: Abdur Rahman
authors.initials: AR
authors.lastname: Khan
authors.affiliation: Kansas City, Missouri.
authors.forename: Alan P
authors.initials: AP
authors.lastname: Wimmer
mesh_terms: D001281:Atrial Fibrillation / Q000628:therapy*; D001562:Benzimidazoles / Q000009:adverse effects*; D017115:Catheter Ablation / Q000009:adverse effects*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000209:etiology*; D020521:Stroke / Q000209:etiology*; D013923:Thromboembolism / Q000517:prevention & control*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D001562:Benzimidazoles; D015091:beta-Alanine